Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
The following clinical research trials are now enrolling patients:
Benign rolandic epilepsy
This study, led by Katrina Boyer, MD, and Masanori Takeoka, MD, is recruiting children with BRE, age 6-11, to investigate whether interictal epileptiform discharges are associated with cognitive and behavioral deficits. To be eligible, patients should have fewer than 15 seizures in the prior month, have no psychiatric or brain disorders affecting cognition or behavior, and should be taking no more than two anticonvulsants.
Children will undergo EEG studies and a neuropsychological screening. For more information contact firstname.lastname@example.org or email@example.com.
Ohtahara syndrome is an epileptic encephalopathy with onset in the newborn period, characterized bytonic spasms, partial seizures, and burst suppression on the EEG. As part of a larger study on the Genetics of Epilepsy and Related Neurological Disorders, we are enrolling children with Ohtahara syndrome and their immediate family members to investigate genetic causes.
Families can provide blood samples without traveling to Boston Children’s Hospital. For more information contact EpilepsyGenetics@Childrens.Harvard.edu.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”